These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32720420)

  • 21. Chilblain-like lesions and COVID-19 infection: A prospective observational study at Spain's ground zero.
    Feito-Rodríguez M; Mayor-Ibarguren A; Cámara-Hijón C; Montero-Vega D; Servera-Negre G; Ruiz-Bravo E; Nozal P; Rodríguez-Peralto JL; Enguita AB; Bravo-Gallego LY; Granados-Fernández M; Fernández-Alcalde C; Fernández-Heredero Á; Alonso-Riaño M; Jiménez-Yuste V; Nuño-González A; De Lucas-Laguna R; López-Granados E; Herranz-Pinto P
    J Am Acad Dermatol; 2021 Feb; 84(2):507-509. PubMed ID: 33022305
    [No Abstract]   [Full Text] [Related]  

  • 22. Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?
    Ramondetta A; Panzone M; Dapavo P; Ortoncelli M; Giura MT; Licciardello M; Rozzo G; Siliquini N; Fierro MT; Ribero S
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e440-e441. PubMed ID: 32421876
    [No Abstract]   [Full Text] [Related]  

  • 23. A case of onychomadesis associated with chilblain-like lesions after COVID-19 infection.
    Colonna C; Giacalone S; Zussino M; Monzani NA; Cambiaghi S; Cavalli R
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e668-e669. PubMed ID: 35535454
    [No Abstract]   [Full Text] [Related]  

  • 24. Cutaneous signs in COVID-19 patients: A review.
    Wollina U; Karadağ AS; Rowland-Payne C; Chiriac A; Lotti T
    Dermatol Ther; 2020 Sep; 33(5):e13549. PubMed ID: 32390279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chilblain-like eruption in COVID-19 disease: possible pathogenetic role of temperature.
    Wee C; Tey HL
    Eur J Dermatol; 2020 Dec; 30(6):764-765. PubMed ID: 33319768
    [No Abstract]   [Full Text] [Related]  

  • 26. Perniosis-like erythema after SARS-CoV2 infection reactivated by vaccination with inactivated virus.
    Campos Garcia L; Barcelos VM; Macedo de Alcântara M; Valadares PJC
    An Bras Dermatol; 2023; 98(4):552-554. PubMed ID: 37003902
    [No Abstract]   [Full Text] [Related]  

  • 27. Coexisting Purpuric and Pseudo-Chilblain Lesions in COVID-19 Patients.
    Tammaro A; Alexander S; Adebanjo GAR; Parisella FR; Rello J; Ramirez-Estrada S
    Skinmed; 2022; 20(2):155-158. PubMed ID: 35532774
    [No Abstract]   [Full Text] [Related]  

  • 28. COVID-19 skin manifestations: the new great imitator?
    Shi V; Hsiao JL; Shi VY
    Dermatol Online J; 2020 Nov; 26(11):. PubMed ID: 33342186
    [No Abstract]   [Full Text] [Related]  

  • 29. Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association?
    Karamanakos A; Evangelatos G; Pappa M; Fragiadaki K; Fanouriakis A; Fragoulis GE
    J Rheumatol; 2022 Nov; 49(11):1295-1296. PubMed ID: 35914789
    [No Abstract]   [Full Text] [Related]  

  • 30. COVID toes: Phenomenon or epiphenomenon?
    Deutsch A; Blasiak R; Keyes A; Wu J; Marmon S; Asrani F; Moy J; Russo M; McLellan BN
    J Am Acad Dermatol; 2020 Nov; 83(5):e347-e348. PubMed ID: 32682878
    [No Abstract]   [Full Text] [Related]  

  • 31. COVID-19 and outbreak of chilblains: are they related?
    Lesort C; Kanitakis J; Villani A; Ducroux E; Bouschon P; Fattouh K; Bensaid B; Danset M; Jullien D
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):e757-e758. PubMed ID: 32594575
    [No Abstract]   [Full Text] [Related]  

  • 32. Two cases of perniosis in a free flap and a graft site of the hands.
    Semkova K; Ong ELH; Jullie M; Beteta V; Santos-Bris A; Bernardis C; Calonje E
    Clin Exp Dermatol; 2019 Oct; 44(7):824-826. PubMed ID: 30628107
    [No Abstract]   [Full Text] [Related]  

  • 33. Juvenile Spring Eruption: A Variant of Perniosis?
    Nabatian AS; Rosman IS; Sturza J; Jacobson M
    Am J Dermatopathol; 2015 Sep; 37(9):721-3. PubMed ID: 26291421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perniosis-like lesions after vaccination with mRNA against COVID-19.
    Pérez-López I; Gil-Villalba A; Ruiz-Villaverde R
    Med Clin (Barc); 2022 Feb; 158(4):189-190. PubMed ID: 34229882
    [No Abstract]   [Full Text] [Related]  

  • 35. COVID-19 pandemic-associated chilblains: more links for SARS-CoV-2 and less evidence for high interferon type I systemic response.
    Bessis D; Trouillet-Assant S; Secco LP; Bardin N; Blanc B; Blatière V; Chable-Bessia C; Delfour C; Girard C; Richard JC; Gros N; Le Moing V; Molinari N; Pallure V; Pisoni A; Raison-Peyron N; Reynaud E; Schwob É; Pescarmona R; Samaran Q; Willems M; Vincent T; Sofonea MT; Belot A; Tuaillon É
    Br J Dermatol; 2022 Dec; 187(6):1032-1035. PubMed ID: 35971922
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapy for probable COVID-19 associated erythema pernio-like lesions in pediatric age. Case report.
    Ruggiero G; Arcangeli F; Lotti T
    Dermatol Ther; 2020 Jul; 33(4):e13616. PubMed ID: 32424851
    [No Abstract]   [Full Text] [Related]  

  • 37. Post SARS-CoV-2 Vaccine Chilblains-like Lesions.
    Mungmunpuntipantip R; Wiwanitkit V
    J Rheumatol; 2022 Jul; 49(7):859. PubMed ID: 35428717
    [No Abstract]   [Full Text] [Related]  

  • 38. Concurrent chilblains and retinal vasculitis in a child with COVID-19.
    Quintana-Castanedo L; Feito-Rodríguez M; Fernández-Alcalde C; Granados-Fernández M; Montero-Vega D; Mayor-Ibarguren A; de Lucas-Laguna R
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):e764-e766. PubMed ID: 32618041
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognosis of rash and chilblain-like lesions among outpatients with COVID-19: a large cohort study.
    Mascitti H; Jourdain P; Bleibtreu A; Jaulmes L; Dechartres A; Lescure X; Yordanov Y; Dinh A;
    Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2243-2248. PubMed ID: 34255231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comment on 'Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East': pernio unrelated to COVID-19.
    Torres-Navarro I; Abril-Pérez C; Roca-Ginés J; Sánchez-Arráez J; Botella-Estrada R; Évole-Buselli M
    Clin Exp Dermatol; 2020 Aug; 45(6):752-754. PubMed ID: 32356578
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.